# ELFABRIO

NDC: 10122-165
Generic name: pegunigalsidase alfa
Labeler / Manufacturer: Chiesi USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20230523

FDA application: BLA761161

## Active ingredients

- PEGUNIGALSIDASE ALFA: 5 mg/2.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10122-165"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10122-165
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fb674bf-744e-431f-92ef-b2a5a66c8cf3
